Virtus LifeSci Biotech Clinical Trials ETF (BBC)
15.70
+0.86
(+5.80%)
USD |
NYSEARCA |
Apr 11, 16:00
15.85
+0.15
(+0.95%)
Pre-Market: 08:07
Key Stats
Customize
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.79% | -0.15% | 9.434M | 86486.00 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.00% | 77.00% | 7.355M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks investment results that correspond to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. The Index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering clinical trial stage of development. |
| General | |
| Security Type | Exchange-Traded Fund |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | Virtus |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of April 14, 2025.
Asset Allocation
As of February 28, 2025.
| Type | % Net |
|---|---|
| Cash | 1.98% |
| Stock | 98.02% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Basic Info
| Investment Strategy | |
| The Fund seeks investment results that correspond to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. The Index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering clinical trial stage of development. |
| General | |
| Security Type | Exchange-Traded Fund |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | Virtus |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |